Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension.

Tetsuro Yokokawa Olivier BoucheratSandra MartineauSarah-Eve LemaySandra Breuils-BonnetVinod Krishna Shanker Kalyana-Sundaram Jey JeyaseelanFrançois PotusSebastien Bonnet Steeve Provencher

Published in: Journal of the American Heart Association (2024)

In addition to revealing new actors likely involved in cardiopulmonary remodeling in PAH, our screening identified promising circulating biomarkers to improve risk prediction in PAH, which should be externally confirmed.

Keyphrases

pulmonary arterial hypertension
pulmonary artery
pulmonary hypertension
polycyclic aromatic hydrocarbons
mass spectrometry
oxidative stress
coronary artery